Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. slides, 8-K earnings release, 10-K stay in one workspace.
ABOS
$2.03
-4.69%
ABOS
· Acumen Pharmaceuticals, Inc.
$2.03
-0.10 (-4.69%)
At close · Oct 6
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 12, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Accordingly, management has concluded that substantial doubt exists regarding our ability to continue as a going concern.”View the 10-Q filed Aug 12, 2026
Market Cap
$159.46M
Shares
72.32M
Volume · Oct 6
562.88K
Avg daily vol (3M)
424.88K
All webcasts
Earnings call · FY2024 Q4
Acumen Pharmaceuticals, Inc. (ABOS) Q4 2024 Earnings Call
Research coverage
3 live sources
Open each available source without leaving this research workspace.
Net income · derived Q4
-$37.15M
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Mar 27, 2025 · complete as-filed document
SEC periodic report
10-K report
Filed Mar 27, 2025 · complete as-filed document